Tag: Active Pharmaceuticals Ingredients
Bulk Drug Park set to boost Domestic Production: Gujarat
Bulk Drug Park
In a significant move towards enhancing India's pharmaceutical self-sufficiency, the anticipated bulk drug park in...
Pharma API Leaders discusses regulatory compliance
Pharma API Leaders discussion
The Pharma active pharmaceuticals ingredients (API) Leaders Conclave, held in Mumbai from March 2...
Steep rise in prices of APIs hits Indian Pharma Companies
Steep rise in active pharmaceuticals Ingredients (API)
The Indian pharmaceutical industry has been facing a steep increase of...
API manufacturing finally getting the attention it deserves
A recent report from Candle Partners forecasts interesting trends for India’s pharma sector.
While investors seemed to be gung...
20 projects worth Rs. 840 crore for PLI scheme for Bulk...
A total of 20 projects under the production linked incentive (PLI) scheme for bulk drugs, conceived by the Central government to support...
USFDA gives warning letter to Aurobindo Pharma for API facility
Aurobindo Pharma yesterday said it has received a warning letter from the US health regulator for its Hyderabad-based Unit I, an Active...
Cost of Raw Materials for Drugs increased from 11% to 51%
Cost of Raw Materials for Drugs increased
The drastic increase in prices of key active pharmaceutical ingredients (APIs)...
Govt allows import of Oxytocin API: Read details
Download notification: The Union health ministry has exempted import of active pharmaceutical ingredient (API) of peptide hormone oxytocin to the country for...
IOL Chemicals & Pharma gets nod for 2 APIs
New Delhi: Drug firm IOL Chemicals & Pharmaceuticals on Thursday said that it has received nod from the Korean Ministry of Food and Drug Safety for...
China ने महंगे किए salt, दोगुना तक हुई Medicines की cost
लगातार बिगड़ रहे रिश्तों के कारण चीन अब देश के फार्मा उद्योग को सीधे तौर पर हिट करने की कोशिश में लगा...
DoP notifies Rs 15,000 crore PLI scheme to boost domestic manufacturing...
The Department of Pharmaceuticals (DoP) has notified new production linked incentive (PLI) scheme following approval by the Cabinet chaired by Prime Minister...
Dr Reddy’s gets 3 observations from USFDA for US-based API plant
Dr Reddy''s Laboratories on Wednesday said the US health regulator has issued a Form 483 with three observations after inspecting its manufacturing...
Guidance document: monographs for Indian Pharmacopoeia: IPC
The Indian Pharmacopoeia Commission (IPC) has released the Guidance Document for Drafting and Formatting of Monographs for Indian Pharmacopoeia (IP) to guide...
Govt issues environmental clearance for Bulk Drugs
The Union environment ministry has finally issued environmental clearance for active pharmaceutical ingredients (APIs) and intermediates as single category instead of individual...
PLI Scheme for Intermediates and APIs approved
PLI Scheme for Intermediates and APIs approved
The Applications of following companies, which have committed more than the minimum...
Govt needs to make policy to lower production cost in API
Stressing that the Central government needs to formulate an appropriate industrial policy to lower the cost of production and provide more incentives...
India: Pharma export shoots up, ‘China plus one’ policy helps
India's Pharma export shoots up
India’s pharmaceutical industry significantly increased exporting drugs when the world was suffering from the...
Egypt: Red carpet for Indian bulk drug Mfrs
Egypt has rolled out the red carpet for Indian active pharmaceutical ingredient (API) manufacturers to invest in the Suez Canal Economic Zone...
API park likely to come up in Una
API park likely to come up in Una
The state government has decided to send a proposal to the...
Short term PLI scheme to boost domestic mfg of excipients: DoP
The Department of Pharmaceuticals (DoP) is working on a short term production linked incentive (PLI) scheme to boost domestic manufacturing of excipients....
चीन की वजह से जल्द महंगी हो सकती है भारत में...
जल्द महंगी हो सकती है भारत में दवाइयां
नई दिल्ली. भारत और चीन (India and China) के बीच चल रहे...
2/3rd of APIs for generic drugs produced in India & China:...
BERLIN (Reuters) - Two-thirds of the active pharmaceuticals ingredients needed to make generic drugs are manufactured in Asia, a study showed on...
2 schemes for bulk drugs manufacturing in India: Govt
The government has prepared two schemes for promoting domestic manufacturing of bulk drugs to reduce the country's dependence on imports, Parliament was informed on...
Video: Manufacturing of API
Manufacturing of API ( ACTIVE PHARMACEUTICAL INGREDIENT)
This is a process documentary done by a group of students on...
Latest posts
5 Essential Benefits of Vitamin C Tablets You Should Know
Benefits of Vitamin C
Benefits of Vitamin C: Vitamin C is crucial for our body, and it is obtained...
Authors
